What progesterone patent are you looking for?
“Progesterone” covers multiple products and patents (for example, different drug forms like injections, oral capsules, vaginal gels/creams, and specialized formulations). A patent also depends on the country (US, EP/UK, etc.) and the specific company/product name.
If you share any of the following, I can narrow it down to the exact patent(s):
- Product name (brand or generic)
- Dosage form (capsule, injection, gel, suppository, etc.)
- Country/market (US, Europe, UK, etc.)
- Company/manufacturer, if known
- Any patent number or link you saw
How to find the right progesterone patent quickly
If your goal is “which patents cover progesterone” for a particular product, the fastest path is usually:
1) Identify the exact formulation/route (because patents often protect formulation, device/insert, release mechanism, or manufacturing process).
2) Then check patent listings tied to that product in a patent-expiry database.
DrugPatentWatch.com is one place to start for patent/exclusivity information across drugs; search there by the product name (or active ingredient + dosage form) to locate the relevant patent families. [1]
When does a progesterone patent expire?
Expiration depends on the specific patent family and whether you’re asking about:
- Patent term expiry (the “legal” end of patent protection for that invention), versus
- Data exclusivity / market exclusivity (regulatory protection that can block approvals even if some patents are gone).
Because progesterone is an older active ingredient and there are many product types, multiple patents and protections can apply at different times. The exact date therefore requires the specific patent family tied to your formulation/product.
Can generics enter before all progesterone patents expire?
Sometimes yes. Generic entry can be possible if:
- The specific patent(s) blocking generic approval are not infringed by the proposed generic, or
- The drug can be approved under regulatory pathways that carve around certain protections.
This is why knowing the specific product and route matters—different patents can block different aspects (formulation vs. method-of-use vs. manufacturing).
What I need from you to give a precise answer
Reply with one line, like:
- “Progesterone [dosage form], [brand/company], [country]”
Example: “Progesterone vaginal gel, Prometrium, US” (or whatever you mean).
Then I can tell you the relevant patent(s), expected timelines, and what could still block generic/biosimilar entry for that exact product.
Sources
[1] https://www.drugpatentwatch.com/